• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

georgia.deliyannis@unimelb.edu.au

Credentials


Position
Research Fellow
Department of Microbiology and Immunology
Education
PhD
University of Melbourne
Bachelors Degree (Honours)
University of Melbourne
ORCID

0000-0002-6883-797X

Dr Georgia Deliyannis

Research Fellow
Department of Microbiology and Immunology

48 Scholarly works
5 Projects

HIGHLIGHTS

  • 2026

    Research contracts (non-grants)

    Production of Proteins for Methanogen Vaccine Program
  • 2026

    Journal article

    Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses
    DOI: 10.1126/scitranslmed.aea8621
  • 2025

    Journal article

    Air–Liquid-Interface-Differentiated Human Nose Epithelium: The Benchmark Culture Model for SARS-CoV-2 Infection
    DOI: 10.3390/organoids4030021
  • 2025

    Journal article

    Bovine tracheal organoids for studying Mycoplasma bovis respiratory infections.
    DOI: 10.1016/j.vetmic.2024.110340
  • 2025

    Thesis / Dissertation

    Novel polyvalent RNA vaccines to address SARS-CoV-2 variants
  • 2023

    Research Contracts

    Immunogenicity Study of Immunised Rats
  • 2023

    Journal article

    Development of Matrix-Embedded Bovine Tracheal Organoids to Study the Innate Immune Response against Bovine Respiratory Disease
    DOI: 10.3390/organoids2020007
Georgia Deliyannis

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
    DOI: 10.1016/j.omtm.2024.101380
  • 2024

    Journal article

    Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia
    DOI: 10.1016/j.isci.2024.110009
  • 2024

    Journal article

    Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
    DOI: 10.3390/organoids3010002
  • 2023

    Journal article

    Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
    DOI: 10.1016/j.ebiom.2023.104878
  • 2023

    Journal article

    Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
    DOI: 10.1016/j.ebiom.2023.104574
  • 2022

    Journal article

    Organoid Models of SARS-CoV-2 Infection: What Have We Learned about COVID-19?
    DOI: 10.3390/organoids1010002

RECENT PROJECTS

  • 2025

    Research grants (international)

    (Services Agreement With Gippsland Research Station) Induction of a Sustained Antibody Response to Methanogen Antigens
  • 2015

    Research Contracts

    Development of a Non-Surgical Approach to Animal Castration.

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224